Search Results 271-280 of 24796 for alzheimers
Qualified researchers can request data, biofluids and specimens from the Mayo Clinic Alzheimer's Disease Research Center.
Lewy body dementia, also known as LBD, is the second most common type of dementia after Alzheimer's disease. Protein deposits called Lewy bodies develop in ...
The purpose of this study is to collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved ...
A Study to Evaluate Caregiver Connections via Technology for Patients with Alzheimer's and Other Types of Dementia · Overview · Participation eligibility.
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's ...
These symptoms may affect people with Alzheimer's disease and other types of dementia. The exact cause of sundowning is not known.
Murray previously led research that identified tau, rather than amyloid, as the protein driving cognitive decline in Alzheimer's disease. This work was ...
The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...
About this study. Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the ...
Dr. Ertekin-Taner's laboratory aims to discover and characterize genetic factors underlying the complex genetics of Alzheimer's disease (AD) and related ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!